A Phase 2 Study of AR-67 (7-t-butyldimrthydiltyl-10-hydroxycamptothecin) in Adult Patients with Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/104/30/14

Funding

  • Arno Therapeutics Inc: $16,419.00